Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome.

In an open randomized multicenter comparative study, we evaluated the safety and efficacy of cefepime (CP; 2.0 g given intravenously every 12 h) and ceftazidime (CZ; 2.0 g given intravenously every 8 h) as initial treatment for adult patients with suspected serious bacterial infections. A total of 1...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kieft, H, Hoepelman, A I, Rozenberg-Arska, M, Branger, J M, Voskuil, J H, Geers, A B, Kluyver, M, Hart, H C, Poest-Clement, E, van Beugen, L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1994
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC284473/
https://ncbi.nlm.nih.gov/pubmed/8203833
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia